A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

Clinical trial NCT04641247 · RECRUITING

Trial details

NCT number: NCT04641247
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Neoplasms Breast Neoplasms

Start date: 2021-04-16
Primary completion: 2026-12-28
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.